.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Farmers Insurance
Mallinckrodt
QuintilesIMS
Merck
Fish and Richardson
Healthtrust
Cerilliant
Federal Trade Commission
Novartis

Generated: December 15, 2017

DrugPatentWatch Database Preview

CEFPROZIL Drug Profile

« Back to Dashboard

When do Cefprozil patents expire, and when can generic versions of Cefprozil launch?

Cefprozil is a drug marketed by Apotex Inc, Aurobindo Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Aurobindo Pharma Ltd, Teva, and Wockhardt. and is included in fifteen NDAs.

The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
Drug patent expirations by year for CEFPROZIL

Pharmacology for CEFPROZIL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
TevaCEFPROZILcefprozilTABLET;ORAL065208-002Dec 6, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtCEFPROZILcefprozilTABLET;ORAL065428-001Jun 14, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncCEFPROZILcefprozilFOR SUSPENSION;ORAL065351-001Feb 29, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdCEFPROZILcefprozilTABLET;ORAL065340-002May 24, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdCEFPROZILcefprozilTABLET;ORAL065198-002Dec 13, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareCEFPROZILcefprozilFOR SUSPENSION;ORAL065284-002Dec 30, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo PharmaCEFPROZILcefprozilFOR SUSPENSION;ORAL065381-002Jan 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCEFPROZILcefprozilFOR SUSPENSION;ORAL065257-002Dec 8, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LupinCEFPROZILcefprozilTABLET;ORAL065276-002Dec 8, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareCEFPROZILcefprozilFOR SUSPENSION;ORAL065284-001Dec 30, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fuji
US Department of Justice
Mallinckrodt
Chubb
Cipla
Healthtrust
Daiichi Sankyo
Colorcon
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot